Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis - PubMed (original) (raw)
Review
Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis
S C Manolagas et al. N Engl J Med. 1995.
Abstract
Both osteoblasts and osteoclasts are derived from progenitors that reside in the bone marrow; osteoblasts belong to the mesenchymal lineage of the marrow stroma, and osteoclasts to the hematopoietic lineage. The development of osteoclasts from their progenitors is dependent on stromal-osteoblastic cells, which are a major source of cytokines that are critical in osteoclastogenesis, such as interleukin-6 and interleukin-11. The production of interleukin-6 by stromal osteoblastic cells, as well as the responsiveness of bone marrow cells to cytokines such as interleukin-6 and interleukin-11, is regulated by sex steroids. When gonadal function is lost, the formation of osteoclasts as well as osteoblasts increases in the marrow, both changes apparently mediated by an increase in the production of interleukin-6 and perhaps by an increase in the responsiveness of bone marrow progenitor cells not only to interleukin-6 but also to other cytokines with osteoclastogenic and osteoblastogenic properties. The cellular activity of the bone marrow is also altered by the process of aging. Specifically, senescence may decrease the ability of the marrow to form osteoblast precursors. The association between the dysregulation of osteoclast or osteoblast development in the marrow and the disruption of the balance between bone resorption and bone formation, resulting in the loss of bone, leads to the following notion. Like homeostasis of other regenerating tissues, homeostasis of bone depends on the orderly replenishment of its cellular constituents. Excessive osteoclastogenesis and inadequate osteoblastogenesis are responsible for the mismatch between the formation and resorption of bone in postmenopausal and age-related osteopenia. The recognition that changes in the numbers of bone cells, rather than changes in the activity of individual cells, form the pathogenetic basis of osteoporosis is a major advance in understanding the mechanism of this disease.
Similar articles
- Biology of the basic multicellular unit and the pathophysiology of osteoporosis.
Jilka RL. Jilka RL. Med Pediatr Oncol. 2003 Sep;41(3):182-5. doi: 10.1002/mpo.10334. Med Pediatr Oncol. 2003. PMID: 12868116 Review. - [The physiopathology of osteoporosis: the role of local factors].
Girasole G, Giuliani N. Girasole G, et al. Ann Ital Med Int. 1995 Oct;10 Suppl:9S-17S. Ann Ital Med Int. 1995. PMID: 8562275 Review. Italian. - Reduced expression of interleukin-11 in bone marrow stromal cells of senescence-accelerated mice (SAMP6): relationship to osteopenia with enhanced adipogenesis.
Kodama Y, Takeuchi Y, Suzawa M, Fukumoto S, Murayama H, Yamato H, Fujita T, Kurokawa T, Matsumoto T. Kodama Y, et al. J Bone Miner Res. 1998 Sep;13(9):1370-7. doi: 10.1359/jbmr.1998.13.9.1370. J Bone Miner Res. 1998. PMID: 9738508 - Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M. Kassem M. APMIS Suppl. 1997;71:1-30. APMIS Suppl. 1997. PMID: 9357492 Review. - Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity.
Martin TJ, Ng KW. Martin TJ, et al. J Cell Biochem. 1994 Nov;56(3):357-66. doi: 10.1002/jcb.240560312. J Cell Biochem. 1994. PMID: 7876329 Review.
Cited by
- Osteoporosis in postmenopausal women is associated with disturbances in gut microbiota and migration of peripheral immune cells.
Ma Z, Liu Y, Shen W, Yang J, Wang T, Li Y, Ma J, Zhang X, Wang H. Ma Z, et al. BMC Musculoskelet Disord. 2024 Oct 7;25(1):791. doi: 10.1186/s12891-024-07904-1. BMC Musculoskelet Disord. 2024. PMID: 39375626 Free PMC article. - PRMT6 Epigenetically Drives Metabolic Switch from Fatty Acid Oxidation toward Glycolysis and Promotes Osteoclast Differentiation During Osteoporosis.
Chu W, Peng W, Lu Y, Liu Y, Li Q, Wang H, Wang L, Zhang B, Liu Z, Han L, Ma H, Yang H, Han C, Lu X. Chu W, et al. Adv Sci (Weinh). 2024 Oct;11(40):e2403177. doi: 10.1002/advs.202403177. Epub 2024 Aug 9. Adv Sci (Weinh). 2024. PMID: 39120025 Free PMC article. - Femoral nailing associated with bone marrow emboli in pigs induced a specific increase in blood IL-6 and broad inflammatory responses in the heart and lungs.
Kristiansen S, Storm BS, Emblem ÅE, Grønli RH, Pettersen K, Hilmo J, Jarmund AH, Leth-Olsen M, Nyrnes SA, Nilsen BA, Nielsen EW, Mollnes TE. Kristiansen S, et al. Front Immunol. 2024 Jul 19;15:1396800. doi: 10.3389/fimmu.2024.1396800. eCollection 2024. Front Immunol. 2024. PMID: 39100680 Free PMC article. - Therapeutic Potential of Ginsenosides on Bone Metabolism: A Review of Osteoporosis, Periodontal Disease and Osteoarthritis.
Ko SY. Ko SY. Int J Mol Sci. 2024 May 27;25(11):5828. doi: 10.3390/ijms25115828. Int J Mol Sci. 2024. PMID: 38892015 Free PMC article. Review. - GBA1 as a risk gene for osteoporosis in the specific populations and its role in the development of Gaucher disease.
Wang CH, Huang YN, Liao WL, Hsieh AR, Lin WD, Liu KW, Lu WL, Huang CC, Chien YH, Lee NC, Su PH, Tsai FJ. Wang CH, et al. Orphanet J Rare Dis. 2024 Apr 4;19(1):144. doi: 10.1186/s13023-024-03132-x. Orphanet J Rare Dis. 2024. PMID: 38575988 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical